Lecture psychiatric disorders 10: ADHD Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Which 3 words would you choose to describe ADHD symptoms (and are also DSM criteria)?

A
  • Inattention
  • Hyperactivity
  • Impulsivity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Fill in prevalence percentages:

  • …% - …% of children aged 6-16 years are diagnosed with ADHD.
  • …% of all ADHD patients are boys.
  • In …% - …%, symptoms will persist into adulthood.
A
  • 2-5% of children aged 6-16 years are diagnosed with ADHD.
  • 80% of all ADHD patients are boys.
  • In 30% - 50%, symptoms will persist into adulthood
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What’s the difference between boys and girls with ADHD?

A
  • Boys → externalized symptoms (running and impulsivity), more physically aggressive.
  • Girls → interalized symptoms (inattentiveness and low self-esteem), more verbally aggressive.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which brain structures could be impaired in people with ADHD? Think of these brain structures and pair them with the typical ADHD symptoms.

A
  • Prefrontal cortex → less inhibitory control and thus more impulsive.
  • Cerebellum and caudate nucleus → motor hyperactivity
  • Corpus callosum → less communication between hemispheres
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

These brain regions that have been discovered to be (thought to be) impaired in ADHD are found with neuroimaging. What is a disadvantage of these imaging studies?

A

Most studies are underpowered, where they used less than 20 subject per group. This makes statistics harder, which can cause differences to show up that are not really there.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The fact that most brain imaging studies for ADHD are underpowered, resulted in the generation of a meta-analysis of structural imaging findins in ADHD. What brain regions were found to be most frequently assesed as different in ADHD?

A

Cerebellum, corpus callosum, caudate nucleus and frontal regions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The fact that most brain imaging studies for ADHD are underpowered, resulted in the generation of a meta-analysis of structural imaging findins in ADHD.

What’s the problem with this meta-analysis?

A

That there were differences between studies in experimental design.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What’s the difference between a meta- and mega-analysis?

A
  • Meta-analysis → combining results of independent studies with different experimental designs.
  • Mega-analysis → very large study with more than 1000 subjects, summarizing results of independent studies with the same experimental designs (e.g. using the same MRI data analysis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

A mega-analysis was performed where they looked at the size of different brain areas in children, adolescent and adult patients with ADHD.

What brain regions were identified for being different in ADHD patients and also name which brain regions were newly identified (i.e. not known previously to play a role in ADHD)?

A
  • Nucleus accumbens → previously not found
  • Amygdale → previously not found
  • Caudate nucleus → was already known to change in ADHD patients
  • Hippocampus → previously not found
  • Intracranial volume → was already known
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What’s interesting about identification of the nucleus accumbens (NAc) and amygdala as a brain regions that might play a role in ADHD?

A
  • The NAc plays a role in the reward system of the brain and it might explain why ADHD patients are more likely to take risks.
  • The amygdale is important for emotional regulation, it might explain why ADHD patients have difficulty with emotional regulation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

A mega-analysis was performed where they looked at the size of different brain areas in children, adolescent and adult patients with ADHD.

What did they find?

A

That for the whole group of ADHD patients (children, adolescents and adults) significant small changes in brain regions size were found. They saw in all patients, that there was a small significant decrease in brain size.

However, these changes were not significant for adults. It seems like the decrease in brain region size is restored in adults.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The identification of the reduction in amygdala size in ADHD patients might be important in ADHD diagnosis. Why is this?

A

Because emotional regulation problems often present in patients with ADHD, but this has not yet been included into the official DSM criteria.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How does this mega-analysis contribute to ADHD diagnosis?

A

Their finding confirm that:

  • patients with ADHD have altered brains. An altered brain is seen as an disorder, so ADHD is a disorder of the brain.
  • This helps reduces the stigma that ADHD is just a label for difficult children and caused by incompetent parenting.
  • Better understanding of ADHD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The publishing of this mega-analysis caused criticism from other scientists. What were these criticisms, what was the reply of the author of the mega-analysis and what are the future goals of the authors?

A
  • Criticism: only small effects are measured, it’s only on group level, it’s heterogeneous and stigmatizing.
  • Reply of author: there were no claims made about causality, only claims about association of these effects to ADHD. So to make a claim about causality, we do need longitudinal studies.
  • Future goals: to develop a growth curve of the brain (similar to body weight) to understand if/when children are at risk for developing ADHD.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

From twin and adoption studies, there have been several behavioral traits and psychiatric disease found that have moderate/high heritability.

What is the heritability of major depression disorder (MDD), ADHD and autism, bipolar disorder and schizophrenia?

A
  • MDD → 40-50%
  • ADHD → 75%
  • Autism, bipolar disorder and schizophrenia → 80%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

So ADHD can be explained in part by the 75% heritability. Some weak associations have been found in two genes that can only account for about 3% of the variation in ADHD. What genes have been found?

A

DAT (dopamine transporter) gene and the DRD4 (dopamine receptor D4) gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

So ADHD can be explained in part by the 75% heritability. Some weak associations have been found in two genes that can only account for about 3% of the variation in ADHD.

What does this suggest?

A

That there are many unidentified common variants with small effects. And that gene-environment or gene-gene interactions, rare variants or a combination of these factors play a prominent role in the genetic cause of ADHD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Are there non-genetic factors that are associated with ADHD?

A

Yes, since only 75% of ADHD variability can be explained by genetics/heritability, 25% should be explained by non-genetic factors.

This is indeed the case, only some non-genetic factors are only found in association with ADHD and some are probably causal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Some non-genetic risk factors have been identified.

Name pre- and perinatal risk factors that are most likely a causal risk factor, but not yet have been proven to be causal risk factor.

A

Maternal smoking, alcohol and substance misuse, maternal stress and low birth weight and prematurity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Some non-genetic risk factors have been identified.

Name environmental risk factors that are most likely a causal risk factor, but not yet have been proven as a causal risk factor.

A

Certain pesticides, PCB and lead

21
Q

Some non-genetic risk factors have been identified.

Name dietary risk factors that correlate as a risk factor, but not yet have been proven as a risk factor.

A

Nutrional deficiencies in certain elements (zinc, magnesium, polyunsaturated fatty acids), nutritional surpluses (sugar, artificial food colourings), low/high IgG foods.

22
Q

Some non-genetic risk factors have been identified.

Name psychosocial adversity risk factors that correlate as a risk factor, but not yet have been proven as a risk factor.

A

Family adversity and low income and conflict/parent-child hostility.

23
Q

What is the only risk factor that is proven as a risk factor and is most likely to be a causal risk factor?

A

Severe early deprivation (seperated by parents, emotional neglect etc.)

24
Q

(I don’t think you need to know all these non-genetic risk factors for ADHD).

But what do these non-genetic risk factors tell us about ADHD?

A

That on top of all the genetic risk factors that contribute to the development of ADHD, there are also many non-genetic risk factors that influence this development. And that together shape the probability, severity and the symptoms of ADHD development.

25
Q

What system in the brain is dysfunctioning in ADHD?

A

The dopamine neurotransmitter system, where it is in a hypodopaminergic condition (significantly reduced levels op dopamine in the brain)

26
Q

Name two drugs that act on the dopamine NT system and explain how they do this.

A

Methylphenidate and (dex)amphetamine, they block reuptake of dopamine by inhibiting dopamine transporters (DAT). This increases the dopamine (DA) concentration.

Note: claiming that ADHD is purely a dopamine disorder, is too symplistic.

27
Q

What kind of study is the Multimodel Treatmnt Study of Children with ADHD (MTA)?

A

A very large longitudinal study in child psychiatry. 579 children, aged 7-9, divided randomly into 4 treatment groups, are included in this study.
They wanted to know whether these treatments are effective, if they are effective compared to behavioural therapy and if there are side effects.

28
Q

What treatments are used in the Multimodel Treatment Study of Children with ADHD (MTA)?

A
  1. Standard community care (treatments by community providers) often with prescribed medication (this treatment is not part of the National Institute for Mental Health (NIMH)) → control group
  2. Intensive behavioral therapy without medication (BT)
  3. Intensive carefully tailored medical treatment with accompanying counseling for child and parents (MED)
  4. Combination of medication and behavioral therapy (COMB)
29
Q

What were the results of the Multimodel Treatment Study of Children with ADHD (MTA)?

A
  • All 4 groups showed sizable reduction in symptoms over time
  • For most ADHD symptoms, children in COMB and MED showed significantly greater improvement than those given intensive BT and community care.
  • The control group used the same medications as the MED group, only the fact that the MED group got carefully tailored medical treatment, caused the MED group to be superior in effectiveness compared to the control group.
  • COMB and MED group did not differ significantly on any direct comparisons for core ADHD symptoms.
  • COMB proved superior for non-ADHD symptoms and positive functioning outcomes.
30
Q

After 8 years a follow-up of the Multimodel Treatment Study of Children with ADHD (MTA) was performed. What were the results?

A
  • There was symptom improvement that was largely maintained after treatment.
  • In nearly every analysis, the 4 groups did not differ significantly on repeated measures or newly analyzed variables.
31
Q

What can be concluded based on the first Multimodel Treatment Study of Children with ADHD (MTA) and the follow-up of this study?

A

That these treatments work on short-term, but in regard to long-term effectiveness; all 4 treatments are ‘equally’ effective. And since these treatments (except the control) are very expensive, the question comes up if it’s beneficial to use expensive treatments if long-term the less expensive options are equally effective.

32
Q

What could be a suggestion based on the first study of the Multimodel Treatment Study of Children with ADHD (MTA) and the follow-up?

A

To temporarily discontinue the medication after 1 or 2 years of treatment, to determine whether benefits of the medication are lost. So if the symptoms come back after discontinuation of the treatment, then the treatment is still useful to continue. But it can also be that the brain has developed/matured enough, that the symptoms have gone away. So then you don’t need the medication anymore.

33
Q

Now we want to know whether ADHD medication has any effects on brain abnormalities, or in other words: if ADHD medication causes any brain normalization of brain areas that are smaller in ADHD patients.

On what two levels can we determine this and what is used to determine this?

A
  • Structural → gray matter volume (i.e. brain region size) by MRI.
  • Functional → connection between brain areas with inhibition and attention tasks by fMRI.
34
Q

Now we want to know whether ADHD medication has any effects on brain abnormalities, or in other words: if ADHD medication causes any brain normalization of brain areas that are smaller in ADHD patients.

What was found when measuring structural brain region size of the grey matter?

A

That the most prominent and replicable structural abnormalities in ADHD are in the basal ganglia. They also see that medications that act on the dopamine system, normalize structural abnormalities, like in the basal ganglia. However, aging is also associated with normalization of structural abnormalities.

35
Q

What contradiction was found between the study that looked at abnormalities in grey matter brain regions and the mega-analysis discussed before?

A

The mega-analysis did not find the same results and so couldn’t replicate these results. They found that: ‘psychostimulant medication did not influence brain area volumes’.

36
Q

What explanation was given by the authors of the mega-analysis in regard to the contradictory results of the study that looked at grey matter brain region sizes?

A
  • That their study (non-randomised, cross-sectional) is not optimal to test for medication effects, so some caution is needed to interpret their result.
  • They also state that they used another technique than other previous meta-analyses, and that their technique could be too local to be picked these observed normalizing effects.
37
Q

Now we want to know whether ADHD medication has any effects on brain abnormalities, or in other words: if ADHD medication causes any brain normalization of brain areas that are smaller in ADHD patients.

What two brain areas were investigated? And what was found when measuring these functional brain areas?

A
  • They looked into two brain areas that connect the frontal lobe with the basal ganglia, that are important for attention.
  • They found that these networks were impaired in patients with ADHD.
  • They also found that medication improved this impairment and caused normalization. This was also found for advancing age.
38
Q

So we now know that medication is effective in ADHD patients and that it doesn’t cause any brain damage. But we still don’t know anything about side effects. Why would we even consider that there might be side effects for these medications?

A

Because methylphenidate and amphetamine closely resemble respectively cocaine and speed. So would administration of these drugs increase the chances of later-life substance abuse/dependence?

39
Q

What was found in a meta-analysis of 2003 in regard to the question whether ADHD medication causes an increased chance of later-life substance abuse?

A

They found that medication in childhood was associated with a reduced risk of drug and alcohol abuse in later-life.

40
Q

What was found in a 2008 study in regard to the question whether ADHD medication causes an increased chance of later-life substance abuse?

A

Their findings revealed that there was no evidence that medication increases or decreases the risk for subsequent substance use disorders in children and adolescent with ADHD when they reach young adulthood.

41
Q

Before 2008, there were almost no studies that tried to replicate the results about increased or decreased chances of substance abuse later in life due to childhood ADHD medication. But from 2008 on, more studies were published that looked into this effect. What was mostly found?

A

That a few studies did find beneficial effects of stimulant medication, meaning that the use of stimulatn medication in young ADHD patients reduced their risk for substance abuse later in life.

Note: these are preliminary results.

42
Q

What was the most important finding in the study that got published in 2017 that looked into the probable beneficial effect of stimulant medication in regard to substance abuse?

A

That well-monitored stimulant treatment may reduce the risk for alcohol and substance use in adolescent ADHD.

43
Q

Why is it so relevant to find a association between well-monitored stimulation medication and the reduced risk for alcohol and substance use in adolescent ADHD?

A

Because ADHD as a condition in itself increases the probability of substance use disorders later on in life (co-morbidity), due to problems with impulse control.

44
Q

There is one side effect of stimulant medication that hasn’t been discussed yet. Name this side effect.

A

Stimulant medication affects growth, medication causes an average growth reduction of 2.0 cm and 2.7 kg.

45
Q

What is neurodiversity?

A

A diversity among human brains in regard to sociability, learning, attention, mood and other important mental functions.

46
Q

What are the negative and positive aspects of ADHD?

A
  • Negative → overly active, low concentration, low impulse control, easily distracted
  • Positive → spontaneous, creative, divergent mind, vital, high-energy, fast-thinking
47
Q

What is the Niche construction?

A

Success in life depends on modifying your surrounding environment to fit the needs of your unique brain. So knowing strenghts and weaknesses of your condition can help with this.

48
Q

What would be the Niche construction for ADHD?

A